Table 3. Factors associated with US-identified HS (logistic regression).
| Variables | Hemodialysis | Control | ||||||
|---|---|---|---|---|---|---|---|---|
| Univariate | Multivariate | Univariate | Multivariate | |||||
| OR (95% CI) | P | OR | P | OR (95% CI) | P | OR | P | |
| Age | 1.01 (0.99–1.03) | 0.370 | - | 1.00 (0.98–1.03) | 0.718 | - | ||
| Male | 0.99 (0.61–1.61) | 0.980 | - | 0.71 (0.41–1.23) | 0.218 | - | ||
| BMI (kg/m2) | 1.25 (1.16–1.36) | <0.001 | 1.21 (1.11–1.32) | <0.001 | 1.20 (1.10–1.31) | <0.001 | 1.15 (1.02–1.29) | 0.027 |
| DM | 1.52 (0.92–2.52) | 0.100 | - | 3.25 (1.71–6.17) | <0.001 | 2.67 (0.99–7.17) | 0.052 | |
| AST (IU/L) | 1.00 (0.97–1.03) | 0.990 | - | 1.00 (0.98–1.01) | 0.870 | - | ||
| ALT(IU/L) | 1.01 (0.99–1.03) | 0.180 | - | 1.02 (1.00–1.03) | 0.026 | 1.02 (0.99–1.04) | 0.061 | |
| Fasting sugar (mg/dL) | 1.01 (1.002–1.01) | 0.002 | 1.00 (0.99–1.01) | 0.22 | 1.01 (0.99–1.03) | 0.259 | - | |
| HDL, male< 40, female < 50(mg/dL) | 2.87 (1.71–4.81) | <0.001 | 1.59 (0.88–2.86) | 0.12 | 1.42 (0.61–3.31) | 0.420 | - | |
| LDL(mg/dL) | 0.99 (0.99–1.01) | 0.850 | - | 1.00 (0.99–1.01) | 0.846 | - | ||
| Total cholesterol(mg/dL) | 1.00 (0.99–1.01) | 0.310 | - | 1.00 (0.99–1.01) | 0.478 | - | ||
| Triglyceride >150(mg/dL) | 3.24 (1.97–5.33) | <0.001 | 1.74 (0.98–3.08) | 0.06 | 2.25 (1.02–4.97) | 0.044 | 1.12 (0.37–3.42) | 0.839 |
| Platelet(1000/μL) | 0.95 (0.55–1.64) | 0.870 | - | 0.17 (0.06–0.48) | 0.001 | 0.25 (0.06–0.99) | 0.050 | |
| LSM (kPa) | 0.95 (0.89–1.02) | 0.180 | - | 0.93 (0.90–0.97) | <0.001 | 0.94 (0.88–0.99) | 0.027 | |
BMI, body mass index; DM, diabetes mellitus; ALT, alanine aminotransferase; AST, aspartate aminotransferase; HDL, High-density lipoprotein; CAP, Controlled Attenuation Parameter; LSM, liver stiffness measurement; LDL, low-density lipoprotein